TipRanks
Sanara MedTech (SMTI)
NASDAQ:SMTI
US Market
SMTI
Sanara MedTech
RESEARCH TOOLSreports
Want to see SMTI full AI Analyst Report?

Sanara MedTech (SMTI) Ratios

49 Followers

Sanara MedTech Ratios

SMTI's free cash flow for Q2 2026 was $0.93. For the 2026 fiscal year, SMTI's free cash flow was decreased by $ and operating cash flow was $0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.58 1.80 2.18 1.38 1.61
Quick Ratio
 2.30 1.59 2.00 1.04 1.33
Cash Ratio
 1.23 0.89 1.04 0.37 0.70
Solvency Ratio
 -0.48 -0.52 -0.10 -0.02 -0.29
Operating Cash Flow Ratio
 0.46 0.36 >-0.01 -0.24 -0.43
Short-Term Operating Cash Flow Coverage
 0.00 19.21 0.00 -5.59 0.00
Net Current Asset Value
$ -29.01M$ -33.47M$ -15.87M$ -10.28M$ 1.30M
Leverage Ratios
Debt-to-Assets Ratio
 0.70 0.66 0.37 0.16 0.01
Debt-to-Equity Ratio
 6.11 8.13 0.82 0.26 0.02
Debt-to-Capital Ratio
 0.86 0.89 0.45 0.21 0.02
Long-Term Debt-to-Capital Ratio
 0.85 0.89 0.44 0.17 0.00
Financial Leverage Ratio
 8.70 12.30 2.24 1.65 1.46
Debt Service Coverage Ratio
 1.30 1.27 -0.59 -0.27 -20.09
Interest Coverage Ratio
 1.42 1.35 -2.15 -8.86 -43.96
Debt to Market Cap
 0.14 0.23 0.11 0.03 0.00
Interest Debt Per Share
 6.44 6.37 4.17 1.48 0.14
Net Debt to EBITDA
 3.50 3.50 -8.82 -22.98 0.70
Profitability Margins
Gross Profit Margin
91.33%90.13%90.61%87.92%86.12%
EBIT Margin
6.35%6.17%-7.83%-6.10%-30.40%
EBITDA Margin
8.61%8.76%-2.15%-0.44%-25.23%
Operating Profit Margin
9.36%8.87%-7.75%-6.49%-27.30%
Pretax Profit Margin
-0.26%-0.38%-11.44%-6.83%-30.40%
Net Profit Margin
-29.15%-36.43%-11.15%-6.62%-17.31%
Continuous Operations Profit Margin
-0.26%-0.38%-11.44%-6.83%-17.65%
Net Income Per EBT
11183.33%9554.90%97.50%96.92%56.95%
EBT Per EBIT
-2.78%-4.30%147.60%105.33%111.34%
Return on Assets (ROA)
-46.30%-51.50%-10.97%-5.83%-13.00%
Return on Equity (ROE)
-473.55%-633.46%-24.53%-9.60%-18.98%
Return on Capital Employed (ROCE)
18.15%16.84%-9.22%-7.01%-25.95%
Return on Invested Capital (ROIC)
18.02%16.73%-9.18%-6.91%-14.97%
Return on Tangible Assets
-66.33%-74.09%-22.23%-16.98%-30.62%
Earnings Yield
-10.54%-18.66%-3.43%-1.26%-2.21%
Efficiency Ratios
Receivables Turnover
 8.73 8.59 6.40 7.62 6.55
Payables Turnover
 6.79 4.35 5.43 3.92 4.46
Inventory Turnover
 2.75 2.58 2.96 1.66 1.79
Fixed Asset Turnover
 47.01 40.72 46.10 19.98 20.62
Asset Turnover
 1.59 1.41 0.98 0.88 0.75
Working Capital Turnover Ratio
 5.90 6.26 7.45 9.96 3.47
Cash Conversion Cycle
 120.71 100.18 113.26 174.15 177.55
Days of Sales Outstanding
 41.79 42.47 57.07 47.92 55.76
Days of Inventory Outstanding
 132.65 141.54 123.45 219.28 203.65
Days of Payables Outstanding
 53.73 83.83 67.25 93.05 81.87
Operating Cycle
 174.44 184.01 180.51 267.20 259.41
Cash Flow Ratios
Operating Cash Flow Per Share
 0.66 0.79 >-0.01 -0.39 -0.70
Free Cash Flow Per Share
 0.52 0.25 -0.03 -0.42 -0.80
CapEx Per Share
 0.14 0.54 0.03 0.03 0.09
Free Cash Flow to Operating Cash Flow
 0.79 0.32 10.64 1.08 1.13
Dividend Paid and CapEx Coverage Ratio
 4.78 1.47 -0.10 -12.24 -7.44
Capital Expenditure Coverage Ratio
 4.78 1.47 -0.10 -12.24 -7.44
Operating Cash Flow Coverage Ratio
 0.12 0.14 >-0.01 -0.28 -6.78
Operating Cash Flow to Sales Ratio
 0.05 0.07 >-0.01 -0.05 -0.12
Free Cash Flow Yield
1.40%1.07%-0.09%-1.03%-1.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -9.43 -5.36 -29.12 -79.07 -45.32
Price-to-Sales (P/S) Ratio
 2.93 1.95 3.25 5.24 7.85
Price-to-Book (P/B) Ratio
 38.22 33.96 7.15 7.59 8.60
Price-to-Free Cash Flow (P/FCF) Ratio
 71.54 93.17 -1.11K -96.92 -57.09
Price-to-Operating Cash Flow Ratio
 53.32 29.67 -11.84K -104.84 -64.76
Price-to-Earnings Growth (PEG) Ratio
 0.03 -0.02 -0.24 1.65 6.12
Enterprise Value Multiple
 37.56 25.80 -160.24 -1.20K -30.40
Enterprise Value
 355.33M 232.96M 298.08M 346.91M 351.62M
EV to EBITDA
 37.56 25.80 -160.24 -1.20K -30.40
EV to Sales
 3.24 2.26 3.44 5.34 7.67
EV to Free Cash Flow
 78.89 107.80 -1.18K -98.81 -55.80
EV to Operating Cash Flow
 62.40 34.33 -12.53K -106.89 -63.30
Tangible Book Value Per Share
 -1.49 -1.89 -0.67 -0.48 0.84
Shareholders’ Equity Per Share
 0.92 0.69 4.64 5.42 5.29
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.42
Revenue Per Share
 12.68 11.96 10.22 7.85 5.80
Net Income Per Share
 -3.70 -4.36 -1.14 -0.52 -1.00
Tax Burden
 111.83 95.55 0.98 0.97 0.57
Interest Burden
 -0.04 -0.06 1.46 1.12 1.00
Research & Development to Revenue
 0.05 0.05 0.07 0.06 0.07
SG&A to Revenue
 0.77 0.76 0.88 0.00 1.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.05 0.05 0.06
Income Quality
 -0.26 -0.25 <0.01 0.73 0.69
Currency in USD